Zhejiang Starry PharmaceuticalLtd Temettü
Temettü kriter kontrolleri 2/6
Zhejiang Starry PharmaceuticalLtd is a dividend paying company with a current yield of 1.15% that is well covered by earnings.
Anahtar bilgiler
1.1%
Temettü verimi
-24.1%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -23.0% |
| Gelecekteki Temettü Verimi | 1.1% |
| Temettü Büyümesi | 3.9% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | CN¥0.100 |
| Ödeme oranı | 56% |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
There's No Escaping Zhejiang Starry Pharmaceutical Co.,Ltd.'s (SHSE:603520) Muted Revenues
Sep 30
Shareholders Can Be Confident That Zhejiang Starry PharmaceuticalLtd's (SHSE:603520) Earnings Are High Quality
May 06Market Might Still Lack Some Conviction On Zhejiang Starry Pharmaceutical Co.,Ltd. (SHSE:603520) Even After 31% Share Price Boost
Mar 12Is Zhejiang Starry PharmaceuticalLtd (SHSE:603520) Using Too Much Debt?
Feb 28Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 603520 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: 603520 has only been paying a dividend for 8 years, and since then payments have fallen.
Piyasaya Karşı Temettü Getirisi
| Zhejiang Starry PharmaceuticalLtd Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (603520) | 1.1% |
| Pazarın Alt %25'i (CN) | 0.6% |
| Pazarın En İyi %25'i (CN) | 2.2% |
| Sektör Ortalaması (Pharmaceuticals) | 1.7% |
| Analist tahmini (603520) (3 yıla kadar) | 1.1% |
Önemli Temettü: 603520's dividend (1.15%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Yüksek Temettü: 603520's dividend (1.15%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonable payout ratio (55.7%), 603520's dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: 603520 is paying a dividend but the company has no free cash flows.